1
|
Kaibori M, Yoshii K, Lai TT, Matsushima H, Tatsuishi W, Inada R, Matsugu Y, Komeda K, Asakuma M, Tanaka K, Sato H, Yamada T, Miyasaka T, Hasegawa Y, Matsui R, Takehara K, Ko S, Yamato I, Washizawa N, Taniguchi H, Kimura Y, Ishibashi N, Akagi Y, Hiki N, Higuchi T, Shingai T, Kamei T, Okamoto H, Nagakawa Y, Takishita C, Kohri T, Matsui K, Nabeya Y, Fukatsu K, Miyata G. Prospective Survey of Postoperative Pain in Japan: A Multicenter, Observational Study. J Clin Med 2025; 14:1130. [PMID: 40004659 PMCID: PMC11856407 DOI: 10.3390/jcm14041130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2025] [Revised: 01/30/2025] [Accepted: 02/07/2025] [Indexed: 02/27/2025] Open
Abstract
Background/Objectives: Postoperative analgesia is important for reducing biologically invasive reactions to surgery. In Japan, postoperative analgesia, including indices of analgesia, has not been adequately addressed. This study aimed to determine the relationship between postoperative pain and postoperative course and the importance of analgesia for early recovery. Methods: Patients who underwent any of seven surgical procedures in gastrointestinal, thoracic, and cardiac surgery were enrolled. The primary endpoint was a median Prince Henry Pain Scale score from postoperative days 1 to 3. Secondary endpoints were the quality of recovery on postoperative day 7 (Quality of Recovery-15 [QoR-15]) and the length of postoperative hospital stay. Results: Median postoperative pain levels among surgeries were 3 on day 1, 2 on days 2 and 3, 1 on day 7, and 1 at discharge. In both univariate and multivariate analyses, the use of postoperative epidural analgesia and intravenous patient-controlled analgesia (IV-PCA) were significant predictors of early postoperative pain. Only early postoperative pain was a significant predictor of QoR-15 score. Regular use of acetaminophen, early postoperative pain, no appetite, and postoperative complications were significant in affecting the length of postoperative hospital stay. In the comparison of early postoperative pain according to whether epidural analgesia and IV-PCA were used, the group that used both methods had the least pain. Conclusions: In Japan, early postoperative pain persists after major surgical procedures and affects postoperative quality of recovery and length of hospital stay. The use of epidural analgesia, IV-PCA, or both appeared to be effective in overcoming early postoperative pain, thereby enhancing early postoperative recovery.
Collapse
Affiliation(s)
- Masaki Kaibori
- Department of Hepatobiliary Surgery, Kansai Medical University, Osaka 573-1010, Japan; (T.T.L.); (H.M.); (K.M.)
| | - Kengo Yoshii
- Department of Mathematics and Statistics in Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan;
| | - Tung Thanh Lai
- Department of Hepatobiliary Surgery, Kansai Medical University, Osaka 573-1010, Japan; (T.T.L.); (H.M.); (K.M.)
- Department of Surgery, Hanoi Medical University, Hanoi 100000, Vietnam
| | - Hideyuki Matsushima
- Department of Hepatobiliary Surgery, Kansai Medical University, Osaka 573-1010, Japan; (T.T.L.); (H.M.); (K.M.)
| | - Wataru Tatsuishi
- Department of Cardiovascular Surgery, Gunma University Hospital, Gunma 371-8511, Japan;
| | - Ryo Inada
- Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi 781-8555, Japan;
| | - Yasuhiro Matsugu
- Department of Gastroenterological Surgery, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan;
| | - Koji Komeda
- Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University Hospital, Osaka 569-8686, Japan; (K.K.); (M.A.); (K.T.)
| | - Mitsuhiro Asakuma
- Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University Hospital, Osaka 569-8686, Japan; (K.K.); (M.A.); (K.T.)
| | - Keitaro Tanaka
- Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University Hospital, Osaka 569-8686, Japan; (K.K.); (M.A.); (K.T.)
| | - Hiroshi Sato
- Department of Gastrointestinal Surgery, Saitama Medical University International Medical Center, Saitama 350-1298, Japan;
| | - Takeshi Yamada
- Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo 113-8603, Japan; (T.Y.); (T.M.)
| | - Toshimitsu Miyasaka
- Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo 113-8603, Japan; (T.Y.); (T.M.)
| | - Yutaka Hasegawa
- Division of Cardiovascular Surgery, Gunma Prefectural Cardiovascular Center, Gunma 371-0004, Japan;
| | - Ryota Matsui
- Department of Digestive and General Surgery, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan; (R.M.); (K.T.)
| | - Kazuhiro Takehara
- Department of Digestive and General Surgery, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan; (R.M.); (K.T.)
| | - Saiho Ko
- Department of Surgery, Nara Prefecture General Medical Center, Nara 630-8581, Japan; (S.K.); (I.Y.)
| | - Ichiro Yamato
- Department of Surgery, Nara Prefecture General Medical Center, Nara 630-8581, Japan; (S.K.); (I.Y.)
| | - Naohiro Washizawa
- Nutritional Therapy Center, Toho University Omori Medical Center, Tokyo143-8541, Japan;
| | - Hideki Taniguchi
- Patient Support Center, Saiseikai Yokohamashi Tobu Hospital, Kanagawa 230-8765, Japan;
| | - Yutaka Kimura
- Department of Surgery, Kindai University Nara Hospital, Nara 630-0293, Japan;
| | - Nobuya Ishibashi
- Department of Surgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan; (N.I.); (Y.A.)
| | - Yoshito Akagi
- Department of Surgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan; (N.I.); (Y.A.)
| | - Naoko Hiki
- Department of Upper Gastrointestinal Surgery, Kitasato University School of Medicine, Kanagawa 252-0373, Japan; (N.H.); (T.H.)
| | - Tadashi Higuchi
- Department of Upper Gastrointestinal Surgery, Kitasato University School of Medicine, Kanagawa 252-0373, Japan; (N.H.); (T.H.)
| | - Tatsushi Shingai
- Department of Surgery, Saiseikai Senri Hospital, Osaka 565-0862, Japan;
| | - Takashi Kamei
- Department of Surgery, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan; (T.K.); (H.O.)
| | - Hiroshi Okamoto
- Department of Surgery, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan; (T.K.); (H.O.)
| | - Yuichi Nagakawa
- Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo 160-8402, Japan; (Y.N.); (C.T.)
| | - Chie Takishita
- Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo 160-8402, Japan; (Y.N.); (C.T.)
| | - Takayuki Kohri
- Department of Surgery, Tone Chuo Hospital, Numata 378-0012, Japan;
| | - Kosuke Matsui
- Department of Hepatobiliary Surgery, Kansai Medical University, Osaka 573-1010, Japan; (T.T.L.); (H.M.); (K.M.)
| | - Yoshihiro Nabeya
- Division of Esophago-Gastrointestinal Surgery, Chiba Cancer Center, Chiba 260-8717, Japan;
| | - Kazuhiko Fukatsu
- Surgical Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan;
| | - Go Miyata
- Department of Digestive Surgery, Iwate Prefectural Central Hospital, Iwate 020-0066, Japan;
| |
Collapse
|
2
|
Li H, Dai W, Zhang X, Lu J, Song F, Li H. Chemical components of Fu brick tea and its potential preventive effects on metabolic syndrome. Food Sci Nutr 2024; 12:35-47. [PMID: 38268870 PMCID: PMC10804099 DOI: 10.1002/fsn3.3771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2023] [Revised: 09/27/2023] [Accepted: 10/04/2023] [Indexed: 01/26/2024] Open
Abstract
As living standards advance, an escalating emphasis is placed on health, particularly in relation to prevalent chronic metabolic disorders. It is necessary to explore safe and effective functional foods or drugs. Fu brick tea (FBT) is a kind of dark tea fermented by fungi. The extracts are rich in compounds that can effectively relieve metabolic diseases such as hyperglycemia and hyperlipidemia, protect the liver, improve human immunity, enhance antioxidant activity, and regulate intestinal flora. This paper summarizes the biological activities and mechanisms of the extracts, polysaccharides, and small molecular compounds of FBT, which provides a certain theoretical basis for the rational, systematic, comprehensive development and utilization of the FBT resources. It is expected to develop and apply these active substances in health care products and natural medicines and provide more beneficial and diversified FBT products for human beings.
Collapse
Affiliation(s)
- Honghua Li
- Key Laboratory of Geriatric Nutrition and Health, Ministry of Education of ChinaSchool of Light IndustryBeijing Technology and Business UniversityBeijingChina
| | - Wei Dai
- Key Laboratory of Geriatric Nutrition and Health, Ministry of Education of ChinaSchool of Light IndustryBeijing Technology and Business UniversityBeijingChina
| | - Xinjun Zhang
- Key Laboratory of Forest Ecology in Tibet Plateau (Ministry of Education), Institute of Tibet Plateau EcologyTibet Agriculture & Animal Husbandry UniversityNyingchiTibetChina
| | - Jie Lu
- Key Laboratory of Forest Ecology in Tibet Plateau (Ministry of Education), Institute of Tibet Plateau EcologyTibet Agriculture & Animal Husbandry UniversityNyingchiTibetChina
| | - Fuhang Song
- Key Laboratory of Geriatric Nutrition and Health, Ministry of Education of ChinaSchool of Light IndustryBeijing Technology and Business UniversityBeijingChina
| | - Hua Li
- Key Laboratory of Geriatric Nutrition and Health, Ministry of Education of ChinaSchool of Light IndustryBeijing Technology and Business UniversityBeijingChina
| |
Collapse
|